| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PRCH | Common Stock | Purchase | $58K | +68.9K | +0.5% | $0.84 | 13.8M | Sep 28, 2023 | Direct | F1, F2 |
| transaction | PRCH | Common Stock | Purchase | $1.95K | +2.44K | +0.02% | $0.80 | 13.8M | Sep 29, 2023 | Direct | F1 |
| transaction | PRCH | Common Stock | Tax liability | -$5.28K | -6.58K | -0.05% | $0.80 | 13.8M | Oct 1, 2023 | Direct | F3 |
| transaction | PRCH | Common Stock | Tax liability | -$2.9K | -3.61K | -0.03% | $0.80 | 13.8M | Oct 1, 2023 | Direct | F4 |
| transaction | PRCH | Common Stock | Tax liability | -$11.6K | -14.4K | -0.1% | $0.80 | 13.8M | Oct 1, 2023 | Direct | F5 |
| transaction | PRCH | Common Stock | Purchase | $53.2K | +67.2K | +0.49% | $0.79 | 13.9M | Oct 2, 2023 | Direct | F6, F7 |
| holding | PRCH | Common Stock | 6.65M | Sep 28, 2023 | By LLC | F8 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Represents a purchase pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on June 2, 2023 (the "10b5-1 Plan"). The 10b5-1 Plan is scheduled to terminate on December 31, 2023 and covers the purchase of up to an aggregate of 2,327,777 shares of the Issuer's common stock. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered. |
| F2 | The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8044 to $0.8600 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F3 | These shares represent shares withheld on semi-annual vesting of the Reporting Person's May 20, 2022 RSU grant. The RSUs will continue to vest ratably on a semi-annual bases over 36 months, with the vesting period commencing on April 1, 2022. |
| F4 | These shares represent shares withheld on the quarterly vesting of the Reporting Person's February 10, 2022 RSU grant. The RSUs will continue to vest ratably on a quarterly basis over 30 months, with the vesting period commencing on October 1, 2021. |
| F5 | These shares represent shares withheld on the quarterly vesting of the Reporting Person's February 10, 2022 RSU grant. The RSUs will continue to vest ratably on a quarterly basis over 36 months, with the vesting period commencing on October 1, 2021. |
| F6 | Represents a purchase pursuant the 10b5-1 Plan. The 10b5-1 Plan is scheduled to terminate on December 31, 2023 and covers the purchase of up to an aggregate of 2,327,777 shares of the Issuer's common stock. Following the purchase on October 2, 2023, all shares of the Issuer's common stock subject to the 10b5-1 Plan had been purchased and the 10b5-1 Plan terminated in accordance with its terms. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered. |
| F7 | The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7907 to $0.7912 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F8 | Issuer common stock held by West Equities, LLC over which the Reporting Person has sole voting and dispositive power. |